Corrigendum to “A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway” [Bioact. Mater. 6 2 (February 2021) 375–385]

Eitemau Tebyg

• A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
  gan: Yinping Zhao, et al.
  Cyhoeddwyd: (2021-02-01)
• Paclitaxel eluting stents versus bare metal stents restenosis
  gan: Ronald Aroche Aportela, et al.
  Cyhoeddwyd: (2021-12-01)
• Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
  gan: Sohila Refahi, et al.
  Cyhoeddwyd: (2019-03-01)
• Risk assessment score for drug eluting stent restenosis
  gan: Z. A. Gabbasov, et al.
  Cyhoeddwyd: (2018-09-01)
• Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
  gan: Porto, I, et al.
  Cyhoeddwyd: (2005)